HIV Drugs Market Size, Share, Trend, Scope Report 2026 to 2035
What is HIV Drugs Market Size? Global HIV Drugs Market Size is valued at USD 40.21 Billion in 2025 and is predicted to reach USD 64.12 Billion by the year 2035 at a 5.0% CAGR during the forecast period for 2026 to 2035. HIV Drugs Market S...
Report ID: 1092 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 170
Gene Therapies For Rare Diseases Market Size, Share & Trends Analysis Report By Product (Zolgensma, Invossa K, Strimvelis, Neovasculgen, Glybera, Luxturna, Zynteglo, and Others), By Disease Type, Region And Segment Forecasts, 2023-2031.
The Gene Therapies For Rare Diseases Market is expected to grow at an 20.0 % CAGR during the forecast period for 2023-2031. Gene Therapy is playing a major role in rare disease management. Gene therapy in rare diseases is a specialized and targete...
Report ID: 1091 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
CBD Pet Market Size, Scope, Forecast Report 2026 to 2035
What is CBD Pet Market Size? CBD Pet Market Size is valued at USD 347.53 million in 2025 and is predicted to reach USD 2,868.57 million by the year 2035 at a 24.3% CAGR during the forecast period for 2026 to 2035. CBD Pet Market Size, Share & T...
Report ID: 1089 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
CAR-T Cell Therapy for Multiple Myeloma Market Size, Share and Growth Analysis 2025 to 2034
What is CAR-T Cell Therapy for Multiple Myeloma Market Size? Global CAR-T Cell Therapy for Multiple Myeloma Market Size is valued at USD 2.32 Billion in 2025 and is predicted to reach USD 9.28 Billion by the year 2035 at an 15.0%...
Report ID: 1088 |
Delivery: Immediate |
Published: March 2026 |
No. of Pages: 170
Oncolytic Virus Therapy Market Research Report with Forecast 2026 to 2035
Gloabal Oncolytic Virus Therapy Market Size is valued at USD 17.35 Million in 2025 and is predicted to reach USD 157.20 Million by the year 2035 at a 25.6% CAGR during the forecast period for 2026 to 2035. ...
Report ID: 1087 |
Delivery: Immediate |
Published: February 2026 |
No. of Pages: 180
Capsule Endoscopy Market Current Trends Analysis 2026 to 2035
What is Capsule Endoscopy Market Size? Global Capsule Endoscopy Market Size is valued at USD 482.98 Million in 2025 and is predicted to reach USD 1049.93 Million by the year 2035 at a 8.2% CAGR during the forecast period for 2026 to 2035 ...
Report ID: 1086 |
Delivery: Immediate |
Published: March 2026 |
No. of Pages: 180
Alternative Proteins Market Current Trends Analysis 2026 to 2035
What is Alternative Proteins Market Size? Alternative Proteins Market Size is valued at USD 18.01 Bn in 2025 and is predicted to reach USD 61.69 Bn by the year 2035 at a 13.70% CAGR during the forecast period for 2026 to 2035. Alternative...
Report ID: 1085 |
Delivery: Immediate |
Published: February 2026 |
No. of Pages: 180
Allogeneic Cell Therapy Market Size, Share and Key Players Analysis 2026 to 2035
What is Allogeneic Cell Therapy Market Size? Allogeneic Cell Therapy Market Size is valued at 1.33 Million in 2025 and is predicted to reach 4.49 Billion by the year 2035 at a 13.30% CAGR during the forecast period for 2026 to 2035. Allog...
Report ID: 1084 |
Delivery: Immediate |
Published: February 2026 |
No. of Pages: 180
Immuno-Oncology Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (CAR-T Cells, NK & NKT Cells, TAA/TSA targeted T Cell, TCR T Cell, and Other Cell Therapies), By Cell Source, By Indication Type, By Region, And Segment Forecasts, 2025-2034
Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remark...
Report ID: 1083 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
AI-Based Clinical Trial Solution Providers Market Size, Share, Scope Report 2026 to 2035
What is AI-Based Clinical Trial Solution Providers Market Size? Global AI-Based Clinical Trial Solution Providers Market Size is valued at USD 2.65 Billion in 2025 and is predicted to reach USD 21.03 Billion by the year 2035 at a 23.7% CAG...
Report ID: 1082 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Rituximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, By Application, By Route of Administration, By Molecule Type, By Distribution Channel Region And Segment Forecasts, 2025-2034
Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indica...
Report ID: 1081 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Trastuzumab Biosimilar Market Size, Share, Trend Report 2026 to 2035
What is Trastuzumab Biosimilar Market Size? Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2026 to 2035. Trastuzumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Ogivri, H...
Report ID: 1080 |
Delivery: Immediate |
Published: January 2026 |
No. of Pages: 180
Anti-Nerve Growth Factor Market Outlook, Clinical Trial/Pipeline Analysis, Competitive Landscape, and Market Forecast Report – 2023 To 2031
The nerve growth factor is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor leads to inflam...
Report ID: 1079 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages:
Cancer Biosimilars Market Size, Share & Trends Analysis Report By Type (Lung Cancer, Breast cancer, Ovarian cancer, Prostate cancer, Lymphoma, Others), By Distribution Channel, By Drug Class, By Route of Administration, Region And Segment Forecasts, 2023-2031
The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031. Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical simil...
Report ID: 1078 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Abdominal Aorta Stent Grafts Market Size, Share & Trends Analysis Report By Product Type (Polymer, Metal), By End-Users (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), Region, And Segment Forecasts, 2025-2034
Global Abdominal Aorta Stent Grafts Market is expected to grow at a 4.9% CAGR during the forecast period for 2025-2034. The Aortic abdominal stent graft is used for abdominal aneurysm endovascular repair. Endovascular aneurysm repair (EVAR), is a ne...
Report ID: 1077 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 170
Filgrastim Biosimilars Market Size, Share & Trends Analysis Report By Application (Febrile Neutropenia, Genital Neutropenia, Idiopathic Neutropenia, and Others), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy), Region And Segment Forecasts, 2023-2031
Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through...
Report ID: 1076 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 175
Global Cancer Immunomodulators Pipeline Market
Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune system. Immunotherapy is a treatment that uses par...
Report ID: 1074 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 140
Bevacizumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Abevmy, Alymsys, Avastin, Avzivi, Avzivi tnjn, Aybintio, Bambevi, Equidacent, Jobevne, Lextemy, Lytenava, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev, and others (including products approved in developing countries and pipeline products), By Application, By Distribution Channel, Region And Segment Forecasts, 2025-2034
Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic act...
Report ID: 1073 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 170
TNF Biosimilars Market Size, Share & Trends Analysis Report By Drug (Adalimumab Biosimilar, Infliximab Biosimilar, Certolizumab Biosimilar, Etanercept Biosimilar, and Golimumab Biosimilar), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), Region And Segment Forecasts, 2025-2034
TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, whic...
Report ID: 1072 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Clinical Trial Site Management, Patient Recruitment Management, (Patient recruitment & registry services, Patient retention, Others), Data Management, Administrative staff, IRB, Others), By Phase, (Phase I, Phase II, Phase III, Phase IV), By Sponsor, By Region, Forecasts, 2024-2031
The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031. The se...
Report ID: 1071 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Pharmaceuticals